| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.2 |
| mRNA | Irinotecan | FIMM | pan-cancer | AAC | 0.15 | 0.2 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.2 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.072 | 0.2 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |